Format

Send to

Choose Destination
Biochem Soc Trans. 2016 Dec 15;44(6):1675-1682.

PHLPPing through history: a decade in the life of PHLPP phosphatases.

Author information

1
Biomedical Sciences Graduate Program, University of California at San Diego, La Jolla, CA 92093-0721, U.S.A.
2
Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093-0721, U.S.A.

Abstract

In the decade since their discovery, the PH domain leucine-rich repeat protein phosphatases (PHLPP) have emerged as critical regulators of cellular homeostasis, and their dysregulation is associated with various pathophysiologies, ranging from cancer to degenerative diseases, such as diabetes and heart disease. The two PHLPP isozymes, PHLPP1 and PHLPP2, were identified in a search for phosphatases that dephosphorylate Akt, and thus suppress growth factor signaling. However, given that there are over 200 000 phosphorylated residues in a single cell, and fewer than 50 Ser/Thr protein phosphatases, it is not surprising that PHLPP has many other cellular functions yet to be discovered, including a recently identified role in regulating the epigenome. Both PHLPP1 and PHLPP2 are commonly deleted in human cancers, supporting a tumor suppressive role. Conversely, the levels of one isozyme, PHLPP1, are elevated in diabetes. Thus, mechanisms to correctly control PHLPP activity in cells are critical for normal cellular homeostasis. This review summarizes the known functions of PHLPP and its role in disease.

KEYWORDS:

PHLPP1; PHLPP2; PP2C; phosphatase; protein kinase B; tumor suppressor

PMID:
27913677
PMCID:
PMC5783572
DOI:
10.1042/BST20160170
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center